Showing posts with label Estrogen Receptor Positive Breast Cancer Pipeline Analysis. Show all posts
Showing posts with label Estrogen Receptor Positive Breast Cancer Pipeline Analysis. Show all posts
Estrogen Receptor-Positive (ER+) Breast Cancer Pipeline to Witness Huge R&D Investment in the Coming Years
Pramod KmrOctober 25, 2017ER Positive Breast Cancer Pipeline Analysis, Estrogen Receptor Positive Breast Cancer Pipeline, Estrogen Receptor Positive Breast Cancer Pipeline Analysis
No comments
The study analyzed that the estrogen
receptor positive breast cancer pipeline comprises approximately 74 drug
candidates in different stages of development.
As per the findings of the
research, a major share of ER+ breast cancer pipeline drug candidates are being
developed to be administered by oral route.










